#TFS_HealthScience

Thiard News@F4F

@newsen.bsky.social

8 months ago

TFS HealthScience Expands Ophthalmology Division with Strategic Hiring and Enhanced Delivery Model TFS HealthScience is significantly strengthening its ophthalmology unit by implementing strategic hires and enhancing its delivery model to meet a growing demand in clinical studies.

TFS HealthScience Expands Ophthalmology Division with Strategic Hiring and Enhanced Delivery Model #USA #Clinical_Trials #Lund #ophthalmology #TFS_HealthScience

Thiard News@F4F

@newsen.bsky.social

8 months ago

TFS HealthScience Strengthens Global Ophthalmology Unit With Key Hires TFS HealthScience is enhancing its global ophthalmology segment with strategic hires and an innovative operational model to meet rising clinical trial demands.

TFS HealthScience Strengthens Global Ophthalmology Unit With Key Hires #USA #Clinical_Trials #Lund #ophthalmology #TFS_HealthScience

Thiard News@F4F

@newsen.bsky.social

8 months ago

TFS HealthScience Expands Global Ophthalmology Unit with Key Strategic Hires TFS HealthScience is enhancing its global ophthalmology unit by adding strategic leadership to meet the rising demand for clinical trials in eye care, with aims to improve patient outcomes.

TFS HealthScience Expands Global Ophthalmology Unit with Key Strategic Hires #USA #Clinical_Trials #Lund #ophthalmology #TFS_HealthScience

Thiard News@F4F

@newsen.bsky.social

8 months ago

TFS HealthScience Expands Ophthalmology Unit with New Leadership and Strategies TFS HealthScience strengthens its ophthalmology division through strategic hires and a new operational model to meet rising global demand.

TFS HealthScience Expands Ophthalmology Unit with New Leadership and Strategies #USA #Lund #CRO #ophthalmology #TFS_HealthScience

Thiard News@F4F

@newsen.bsky.social

8 months ago

TFS HealthScience Expands Global Ophthalmology Unit with New Leadership and Advanced Delivery Models TFS HealthScience is enhancing its ophthalmology unit with strategic hires and improved capabilities, addressing the growing demand for clinical trials in eye care.

TFS HealthScience Expands Global Ophthalmology Unit with New Leadership and Advanced Delivery Models #Sweden #Clinical_Trials #Lund #ophthalmology #TFS_HealthScience

Thiard News@F4F

@newsen.bsky.social

10 months ago

TFS HealthScience Deepens Partnership with Oncomatryx for Promising Pancreatic Cancer Drug Trial TFS HealthScience expands its partnership with Oncomatryx to support a Phase Ib trial on OMTX705, a new therapy for advanced pancreatic cancer, highlighting the urgent need for effective treatments in this field.

TFS HealthScience Deepens Partnership with Oncomatryx for Promising Pancreatic Cancer Drug Trial #USA #Lund #TFS_HealthScience #Oncomatryx #OMTX705

Thiard News@F4F

@newsen.bsky.social

10 months ago

TFS HealthScience Expands Collaboration with Oncomatryx for Phase Ib Study of OMTX705 in Pancreatic Cancer TFS HealthScience is deepening its partnership with Oncomatryx to support a Phase Ib clinical trial of OMTX705 for treating advanced pancreatic cancer.

TFS HealthScience Expands Collaboration with Oncomatryx for Phase Ib Study of OMTX705 in Pancreatic Cancer #Sweden #Lund #TFS_HealthScience #Oncomatryx #OMTX705

Thiard News@F4F

@newsen.bsky.social

10 months ago

TFS HealthScience Strengthens Partnership with Oncomatryx for OMTX705 Pancreatic Cancer Trials TFS HealthScience is expanding its collaboration with Oncomatryx for a Phase Ib trial of OMTX705, targeting advanced pancreatic cancer. This collaboration aims to accelerate innovative treatments.

TFS HealthScience Strengthens Partnership with Oncomatryx for OMTX705 Pancreatic Cancer Trials #USA #Lund #TFS_HealthScience #Oncomatryx #OMTX705

Thiard News@F4F

@newsen.bsky.social

10 months ago

TFS HealthScience and Oncomatryx Collaborate for Advanced Pancreatic Cancer Trials TFS HealthScience expands its partnership with Oncomatryx for a Phase Ib trial of OMTX705 targeting advanced pancreatic cancer, aiming to develop innovative therapies.

TFS HealthScience and Oncomatryx Collaborate for Advanced Pancreatic Cancer Trials #USA #Lund #TFS_HealthScience #Oncomatryx #OMTX705

Thiard News@F4F

@newsen.bsky.social

10 months ago

TFS HealthScience and Oncomatryx Join Forces for OMTX705 Pancreatic Cancer Trial TFS HealthScience is furthering its partnership with Oncomatryx to conduct a Phase Ib trial of OMTX705, a potential treatment for pancreatic cancer.

TFS HealthScience and Oncomatryx Join Forces for OMTX705 Pancreatic Cancer Trial #USA #Lund #pancreatic_cancer #TFS_HealthScience #Oncomatryx

Thiard News@F4F

@newsen.bsky.social

11 months ago

TFS HealthScience Appoints Miriam Martin as Vice President of Business Development Miriam Martin has been appointed Vice President of Business Development at TFS HealthScience, enhancing the company's strategic growth and clinical development services.

TFS HealthScience Appoints Miriam Martin as Vice President of Business Development #USA #Lund #Clinical_Development #TFS_HealthScience #Miriam_Martin

Thiard News@F4F

@newsen.bsky.social

1 year ago

TFS HealthScience Announces Leadership Changes with New President and Interim CEO TFS HealthScience reveals the appointment of Katarina Ageborg as Chairwoman and Markus Granlund as Interim CEO, signaling new directions.

TFS HealthScience Announces Leadership Changes with New President and Interim CEO #Sweden #Lund #TFS_HealthScience #Katarina_Ageborg #Markus_Granlund

Thiard News@F4F

@newsen.bsky.social

1 year ago

TFS HealthScience Announces Changes in Leadership to Propel Growth and Innovation TFS HealthScience has appointed Katarina Ageborg as CEO and Markus Granlund as interim managing director, marking a significant leadership shift aimed at enhancing operations and client relationships.

TFS HealthScience Announces Changes in Leadership to Propel Growth and Innovation #USA #Lund #TFS_HealthScience #Katarina_Ageborg #Markus_Granlund

Thiard News@F4F

@newsen.bsky.social

1 year ago

TFS HealthScience Announces New Leadership Transition and Strategy for Growth TFS HealthScience has appointed Katarina Ageborg as Chair and Markus Granlund as Acting CEO, marking a significant leadership transition aimed at enhancing client partnerships and growth.

TFS HealthScience Announces New Leadership Transition and Strategy for Growth #USA #Lund #TFS_HealthScience #Katarina_Ageborg #Markus_Granlund

Thiard News@F4F

@newsen.bsky.social

1 year ago

TFS HealthScience Welcomes New Leadership with Katarina Ageborg as Chairman and Markus Granlund as CEO TFS HealthScience has appointed Katarina Ageborg as Chairman and Markus Granlund as acting CEO, marking a new era of leadership focused on global growth and innovation.

TFS HealthScience Welcomes New Leadership with Katarina Ageborg as Chairman and Markus Granlund as CEO #Sweden #Lund #TFS_HealthScience #Katarina_Ageborg #Markus_Granlund

Thiard News@F4F

@newsen.bsky.social

1 year ago

TFS HealthScience Appoints New Leaders to Drive Future Growth and Innovation in Clinical Research TFS HealthScience announces a leadership transition, appointing Katarina Ageborg as Chairman and Markus Granlund as acting CEO to enhance its position in clinical research.

TFS HealthScience Appoints New Leaders to Drive Future Growth and Innovation in Clinical Research #Sweden #Lund #TFS_HealthScience #Katarina_Ageborg #Markus_Granlund